| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
102,087,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
3,941,702 |
Avg
Vol: |
1,828,512 |
| 52
Week Range: |
$45.85 - $45.85 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pauwels Eric |
President, NPS Pharma Intl |
• – – |
2015-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,867 |
24,766 |
|
- |
|
| Beshar Luke M |
EVP & CFO |
• – – |
2015-02-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
62,780 |
|
- |
|
| Rogus Joseph J |
SVP, GTO & Supply Chain Mngmt |
• – – |
2015-02-05 |
4 |
S |
$45.90 |
$1,497,245 |
D/D |
(32,622) |
20,151 |
|
- |
|
| Rogus Joseph J |
SVP, GTO & Supply Chain Mngmt |
• – – |
2015-02-05 |
4 |
OE |
$3.34 |
$247,726 |
D/D |
32,622 |
52,773 |
|
- |
|
| Garceau Roger |
SVP & CMO |
• – – |
2015-02-05 |
4 |
OE |
$45.88 |
$705,818 |
D/D |
15,384 |
52,448 |
|
- |
|
| Beshar Luke M |
EVP & CFO |
• – – |
2014-12-17 |
4 |
AS |
$35.00 |
$1,829,030 |
D/D |
(52,258) |
72,780 |
|
- |
|
| Beshar Luke M |
EVP & CFO |
• – – |
2014-12-17 |
4 |
OE |
$3.34 |
$373,670 |
D/D |
52,258 |
125,038 |
|
- |
|
| Rogus Joseph J |
SVP Gbl Tech Oper Sup Chn Mgt |
• – – |
2014-12-17 |
4 |
AS |
$35.00 |
$576,345 |
D/D |
(16,467) |
20,151 |
|
- |
|
| Rogus Joseph J |
SVP Gbl Tech Oper Sup Chn Mgt |
• – – |
2014-12-17 |
4 |
OE |
$3.34 |
$63,849 |
D/D |
16,467 |
36,618 |
|
- |
|
| Selisker Rachel R |
Director |
– • – |
2014-12-17 |
4 |
AS |
$34.59 |
$128,260 |
D/D |
(3,708) |
7,400 |
|
- |
|
| Selisker Rachel R |
Director |
– • – |
2014-12-17 |
4 |
OE |
$4.24 |
$5,122 |
D/D |
1,208 |
11,108 |
|
- |
|
| Selisker Rachel R |
Director |
– • – |
2014-12-08 |
4 |
AS |
$34.50 |
$798,981 |
D/D |
(23,157) |
9,900 |
|
- |
|
| Selisker Rachel R |
Director |
– • – |
2014-12-08 |
4 |
OE |
$4.24 |
$98,186 |
D/D |
23,157 |
33,057 |
|
- |
|
| Selisker Rachel R |
Director |
– • – |
2014-11-28 |
4 |
AS |
$34.50 |
$401,418 |
D/D |
(11,635) |
9,900 |
|
- |
|
| Selisker Rachel R |
Director |
– • – |
2014-11-28 |
4 |
OE |
$4.24 |
$49,332 |
D/D |
11,635 |
21,535 |
|
- |
|
| Beshar Luke M |
EVP & CFO |
• – – |
2014-11-17 |
4 |
AS |
$30.01 |
$1,423,640 |
D/D |
(47,442) |
72,780 |
|
- |
|
| Beshar Luke M |
EVP & CFO |
• – – |
2014-11-17 |
4 |
OE |
$3.34 |
$223,564 |
D/D |
47,442 |
120,222 |
|
- |
|
| Rogus Joseph J |
SVP, Gbl Technical Operations |
• – – |
2014-11-17 |
4 |
AS |
$30.00 |
$803,540 |
D/D |
(26,782) |
20,151 |
|
- |
|
| Rogus Joseph J |
SVP, Gbl Technical Operations |
• – – |
2014-11-17 |
4 |
OE |
$3.34 |
$89,452 |
D/D |
26,782 |
46,933 |
|
- |
|
| Selisker Rachel R |
Director |
– • – |
2014-11-11 |
4 |
AS |
$29.50 |
$448,087 |
D/D |
(15,188) |
9,900 |
|
- |
|
| Beshar Luke M |
EVP & CFO |
• – – |
2014-10-31 |
4 |
AS |
$29.00 |
$290,000 |
D/D |
(10,000) |
72,780 |
|
- |
|
| Beshar Luke M |
EVP & CFO |
• – – |
2014-10-27 |
4 |
AS |
$26.75 |
$819,606 |
D/D |
(30,635) |
82,780 |
|
- |
|
| Pauwels Eric |
President, NPS Pharma Intl |
• – – |
2014-09-26 |
4 |
D |
$27.55 |
$142,847 |
D/D |
(5,185) |
24,766 |
|
- |
|
| Pauwels Eric |
President, NPS Pharma Intl |
• – – |
2014-09-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
29,951 |
|
- |
|
| Beshar Luke M |
EVP & CFO |
• – – |
2014-08-13 |
4 |
OE |
$3.34 |
$185,915 |
D/D |
53,813 |
113,415 |
|
- |
|
574 Records found
|
|
Page 3 of 23 |
|
|
